Initially selected in 2018, TransPerfect’s Trial Interactive has become the preferred eTMF partner for SCOPE’s clinical trials in all major indications across phases I–IV. With continuous platform innovation and feature updates, SCOPE felt confident scaling with the platform for new studies.
The partnership between TransPerfect and SCOPE is providing significant advantages to sponsors, including quicker setup times for new trials, reduced initial costs, and more efficient file management through an application programming interface (API). These improvements have not only ensured the timely management of Trial Master Files (TMF) but have also optimized budgets for TMF maintenance, demonstrating a commitment to leveraging innovative solutions for more cost-efficient and effective clinical trial management.